1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Johnson, B.A.
Stevens, S.P.
Williamson, J.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
33
15061
15070
10.1021/bi00254a015
7999764
Determination of the three-dimensional structure of margatoxin by 1H, 13C, 15N triple-resonance nuclear magnetic resonance spectroscopy.
1994
10.2210/pdb1mtx/pdb
pdb_00001mtx
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4192.048
MARGATOXIN
1
nat
polymer
no
no
TIINVKCTSPKQCLPPCKAQFGQSAGAKCMNGKCKCYPH
TIINVKCTSPKQCLPPCKAQFGQSAGAKCMNGKCKCYPH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Centruroides
sample
29018
Centruroides margaritatus
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1995-11-14
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1994-12-27
REL
23
BRUNGER
refinement
X-PLOR
THR
1
n
1
THR
1
A
ILE
2
n
2
ILE
2
A
ILE
3
n
3
ILE
3
A
ASN
4
n
4
ASN
4
A
VAL
5
n
5
VAL
5
A
LYS
6
n
6
LYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
PRO
10
n
10
PRO
10
A
LYS
11
n
11
LYS
11
A
GLN
12
n
12
GLN
12
A
CYS
13
n
13
CYS
13
A
LEU
14
n
14
LEU
14
A
PRO
15
n
15
PRO
15
A
PRO
16
n
16
PRO
16
A
CYS
17
n
17
CYS
17
A
LYS
18
n
18
LYS
18
A
ALA
19
n
19
ALA
19
A
GLN
20
n
20
GLN
20
A
PHE
21
n
21
PHE
21
A
GLY
22
n
22
GLY
22
A
GLN
23
n
23
GLN
23
A
SER
24
n
24
SER
24
A
ALA
25
n
25
ALA
25
A
GLY
26
n
26
GLY
26
A
ALA
27
n
27
ALA
27
A
LYS
28
n
28
LYS
28
A
CYS
29
n
29
CYS
29
A
MET
30
n
30
MET
30
A
ASN
31
n
31
ASN
31
A
GLY
32
n
32
GLY
32
A
LYS
33
n
33
LYS
33
A
CYS
34
n
34
CYS
34
A
LYS
35
n
35
LYS
35
A
CYS
36
n
36
CYS
36
A
TYR
37
n
37
TYR
37
A
PRO
38
n
38
PRO
38
A
HIS
39
n
39
HIS
39
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
GLY
26
A
O
GLY
26
A
N
TYR
37
A
N
TYR
37
1
A
ASN
4
-88.40
31.93
1
A
ASN
31
4.82
65.65
2
A
ASN
4
-113.75
56.94
2
A
ALA
19
-87.11
33.22
2
A
GLN
20
-131.81
-61.18
2
A
ASN
31
4.81
65.84
3
A
ASN
4
-111.08
78.98
3
A
ASN
31
4.66
66.56
4
A
GLN
20
-106.88
-62.94
4
A
LYS
28
-119.05
-168.30
4
A
MET
30
-95.18
-141.38
4
A
ASN
31
-38.43
-30.31
5
A
GLN
20
-106.90
-61.37
5
A
ASN
31
4.89
65.98
5
A
PRO
38
-59.92
107.69
6
A
ASN
31
4.99
65.82
7
A
ASN
4
-112.18
66.85
7
A
PHE
21
-96.65
-65.35
7
A
MET
30
-154.31
40.28
7
A
ASN
31
179.87
39.73
8
A
ASN
31
4.77
65.89
9
A
ASN
4
-105.07
78.44
9
A
ASN
31
5.05
65.71
10
A
ASN
4
-85.41
49.01
10
A
ASN
31
4.76
65.81
11
A
GLN
20
-137.36
-55.64
11
A
MET
30
-85.38
-140.07
12
A
GLN
20
-109.26
-64.96
12
A
ASN
31
4.82
65.54
13
A
GLN
20
-125.78
-57.03
13
A
ASN
31
4.86
65.67
13
A
PRO
38
-60.99
90.61
14
A
LYS
28
-123.10
-168.92
14
A
MET
30
-84.56
-140.29
15
A
ASN
4
-109.45
76.20
15
A
GLN
20
-120.13
-54.65
15
A
MET
30
-155.39
28.86
15
A
ASN
31
-167.53
43.43
16
A
GLN
20
-104.47
-61.70
16
A
MET
30
-84.72
-103.78
17
A
ASN
4
-110.80
65.74
17
A
GLN
20
-126.65
-57.27
17
A
LYS
28
-126.39
-168.21
17
A
MET
30
-84.72
-143.02
18
A
GLN
20
-93.93
-61.86
18
A
MET
30
-98.52
-135.58
18
A
ASN
31
-35.28
-31.22
19
A
ASN
4
-103.22
77.30
19
A
ASN
31
4.93
66.13
20
A
ASN
4
-105.25
78.78
20
A
ASN
31
4.60
66.06
21
A
ASN
4
-109.45
69.48
21
A
MET
30
-84.67
-140.77
22
A
GLN
20
-123.07
-55.87
22
A
ASN
31
4.99
65.62
22
A
PRO
38
-59.90
105.71
23
A
GLN
20
-121.97
-56.35
23
A
ASN
31
4.88
65.82
23
A
PRO
38
-59.11
108.26
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
DETERMINATION OF THE THREE-DIMENSIONAL STRUCTURE OF MARGATOXIN BY 1H, 13C, 15N TRIPLE-RESONANCE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
1
Y
N
A
PRO
10
A
PRO
10
HELX_P
A
GLN
20
A
GLN
20
5
1
11
disulf
2.020
A
CYS
7
A
SG
CYS
7
1_555
A
CYS
29
A
SG
CYS
29
1_555
disulf
2.020
A
CYS
13
A
SG
CYS
13
1_555
A
CYS
34
A
SG
CYS
34
1_555
disulf
2.022
A
CYS
17
A
SG
CYS
17
1_555
A
CYS
36
A
SG
CYS
36
1_555
TOXIN
TOXIN
SCKM_CENMA
UNP
1
1
P40755
TIINVKCTSPKQCLPPCKAQFGQSAGAKCMNGKCKCYPH
1
39
1MTX
1
39
P40755
A
1
1
39
2
anti-parallel
A
GLY
26
A
GLY
26
A
MET
30
A
MET
30
A
LYS
33
A
LYS
33
A
TYR
37
A
TYR
37
1
P 1